344 related articles for article (PubMed ID: 17592071)
1. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
2. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis.
Rupérez M; Lorenzo O; Blanco-Colio LM; Esteban V; Egido J; Ruiz-Ortega M
Circulation; 2003 Sep; 108(12):1499-505. PubMed ID: 12952842
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells.
Sánchez-López E; Rodriguez-Vita J; Cartier C; Rupérez M; Esteban V; Carvajal G; Rodrígues-Díez R; Plaza JJ; Egido J; Ruiz-Ortega M
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F149-60. PubMed ID: 17989112
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
Rodrigues-Díez R; Carvajal-González G; Sánchez-López E; Rodríguez-Vita J; Rodrigues Díez R; Selgas R; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Pharm Res; 2008 Oct; 25(10):2447-61. PubMed ID: 18633694
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.
Rodriguez-Vita J; Ruiz-Ortega M; Rupérez M; Esteban V; Sanchez-López E; Plaza JJ; Egido J
Circ Res; 2005 Jul; 97(2):125-34. PubMed ID: 15976312
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
[TBL] [Abstract][Full Text] [Related]
11. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
[TBL] [Abstract][Full Text] [Related]
13. Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
Rodrigues Díez R; Rodrigues-Díez R; Lavoz C; Rayego-Mateos S; Civantos E; Rodríguez-Vita J; Mezzano S; Ortiz A; Egido J; Ruiz-Ortega M
PLoS One; 2010 Nov; 5(11):e14145. PubMed ID: 21152444
[TBL] [Abstract][Full Text] [Related]
14. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
16. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
[TBL] [Abstract][Full Text] [Related]
17. Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells.
Funakoshi Y; Ichiki T; Shimokawa H; Egashira K; Takeda K; Kaibuchi K; Takeya M; Yoshimura T; Takeshita A
Hypertension; 2001 Jul; 38(1):100-4. PubMed ID: 11463768
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
19. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
20. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways.
Iwanciw D; Rehm M; Porst M; Goppelt-Struebe M
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1782-7. PubMed ID: 12947014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
